GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

T&L Co 340570.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

23,400

0.00%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About T&L Co

Its shares trade on KOSDAQ under the ticker 340570.KQ. It has been listed since 20 November 2020. In the fiscal year to 31 December 2025, it reported revenue of ₩164.16bn and net income of ₩38.07bn. At that date it held total assets of ₩217.08bn and shareholders' equity of ₩201.16bn.

T&L Co., Ltd. develops medical polymer material products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2020-11-20. The firm's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The firm sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
20 Nov 2020
Website
tnl.co.kr ↗

Leadership

Pay as last reported

  • Yoon-So ChoiPresident

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • T&L Co Ltd develops medical polymer material products for the Health Care sector.
  • The firm sells wound treatment materials in domestic and overseas markets.
  • Orthopedic fixing materials include casts and splints for fracture treatment.

Weaknesses

  • The company is headquartered in Yongin, Gyeonggi-Do, South Korea.
  • T&L Co Ltd went IPO on 20 November 2020.
  • Water repellents are listed as main products alongside adhesives.

Opportunities

  • Products are sold in the United States and Germany markets.
  • China and Dubai represent additional overseas markets for sales expansion.
  • Hydrocolloids and foams serve as wetting dressing agents for healing.

Threats

  • Structural adhesives compete in the global medical polymer material market.
  • Hydrogels require specific conditions for effective wound healing applications.
  • International sales face regulatory challenges in diverse overseas regions.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.